Zobrazeno 1 - 10
of 2 480
pro vyhledávání: '"Roboz GJ"'
Autor:
Ravandi F; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Döhner H; Ulm University Hospital, Ulm, Germany., Wei AH; Peter MacCallum Cancer Centre, Melbourne, Australia.; The Royal Melbourne Hospital, Melbourne, Australia., Montesinos P; Hematology Department, Hospital Universitari i Politècnic, La Fe, València, Spain.; CIBERONC, Instituto Carlos III, Madrid, Spain., Pfeilstöcker M; Third Medical Department for Hematology and Oncology, Hanusch Hospital, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria., Papayannidis C; IRCCS, Azienda Ospedaliero Universitaria di Bologna, Istituto di Ematologia 'L. e A. Seràgnoli', Bologna, Italy., Lai Y; Bristol Myers Squibb, Princeton, New Jersey, USA., Wang K; Bristol Myers Squibb, Princeton, New Jersey, USA., See WL; Bristol Myers Squibb, San Francisco, California, USA., de Menezes DL; Bristol Myers Squibb, San Francisco, California, USA., Petrlik E; Bristol Myers Squibb, Princeton, New Jersey, USA., Prebet T; Bristol Myers Squibb, Summit, New Jersey, USA., Roboz GJ; Weill Cornell Medicine, New York, New York, USA.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 Mar; Vol. 204 (3), pp. 877-886. Date of Electronic Publication: 2023 Nov 12.
Autor:
Aldoss I; Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA. Electronic address: ialdoss@coh.org., Roboz GJ; Clinical and Translational Leukemia Program, Weill Medical College of Cornell University, New York, NY, USA., Bassan R; Department of Hematology, Ospedale dell'Angelo and Ospedale SS Giovanni e Paolo, Mestre Venezia, Italy., Boissel N; Department of Hematology, Hôpital Saint-Louis, AP-HP, Institut de Recherche Saint-Louis, Université Paris Cité, Paris, France., DeAngelo DJ; Division of Leukemia, Dana-Farber Cancer Institute, Boston, MA, USA., Fleming S; Hematology Department, The Alfred Hospital, Melbourne, VIC, Australia., Gökbuget N; Department of Haematology and Oncology, Goethe-Universität, University Hospital, Frankfurt, Germany., Logan AC; Department of Hematology and Oncology, University of California, San Francisco, San Francisco, CA, USA., Luger SM; Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, PA, USA., Menne T; Cancer Services and Clinical Haematology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK., Park J; Chief of the Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Schuh AC; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada., Shah B; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2024 Dec; Vol. 11 (12), pp. e959-e970.
Autor:
Lai C; University of Pennsylvania, Philidelphia, Pennsylvania, United States., Lee M; Mayo Clinic, Rochester, Minnesota, United States., Bobek O; Mayo Clinic, Rochester, Minnesota, United States., Le-Rademacher J; Mayo Clinic, Rochester, Minnesota, United States., Mandrekar SJ; Mayo Clinic, Rochester, Minnesota, United States., Roboz GJ; Weill Medical College of Cornell University, New York, New York, United States., Uy GL; Division of Oncology, Washington University School of Medicine, Saint Louis, Missouri, United States., Mandelblatt J; Georgetown University, Washington DC, District of Columbia, United States., Klepin HD; Wake Forest School of Medicine, Winston Salem, North Carolina, United States.
Publikováno v:
Blood advances [Blood Adv] 2024 Nov 27. Date of Electronic Publication: 2024 Nov 27.
Autor:
Komrokji RS; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Lanino L; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Ball S; Division of Hematology and Oncology, Vanderbilt Ingram Cancer Center and Vanderbilt University School of Medicine, Nashville, TN, USA., Bewersdorf JP; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Marchetti M; Azienda Ospedaliera Nazionale SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy., Maggioni G; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy., Travaglino E; IRCCS Polilcinico San Matteo, Pavia, Italy., Al Ali NH; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Fenaux P; Saint Louis Hospital, Paris Cité University, Paris, France., Platzbecker U; University Hospital Leipzig, Leipzig, Germany., Santini V; University of Florence, Florence, Italy., Diez-Campelo M; Haematology Department, University Hospital Salamanca, Salamanca, Spain., Singh A; Cleveland Clinic, Cleveland, OH, USA., Jain AG; Cleveland Clinic, Cleveland, OH, USA., Aguirre LE; Dana Farber Cancer Institute, Boston, MA, USA., Tinsley-Vance SM; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Schwabkey ZI; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Chan O; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Xie Z; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Brunner AM; Dana Farber Cancer Institute, Boston, MA, USA., Kuykendall AT; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Bennett JM; University of Rochester Medical Center, Rochester, NY, USA., Buckstein R; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada., Bejar R; University of California San Diego, San Diego, CA, USA., Carraway HE; Cleveland Clinic, Cleveland, OH, USA., DeZern AE; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USA., Griffiths EA; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Halene S; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA., Hasserjian RP; Massachusetts General Hospital, Boston, MA, USA., Lancet J; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., List AF; Precision BioSciences, Durham, NC, USA., Loghavi S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Odenike O; Leukemia Program, University of Chicago Medicine and University of Chicago Comprehensive Cancer Center, Chicago, IL, USA., Padron E; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Patnaik MM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Roboz GJ; New York-Presbyterian/Weill Cornell Medicine, New York, NY, USA., Stahl M; Dana Farber Cancer Institute, Boston, MA, USA., Sekeres MA; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Steensma DP; Ajax Therapeutics, Cambridge, MA, USA., Savona MR; Division of Hematology and Oncology, Vanderbilt Ingram Cancer Center and Vanderbilt University School of Medicine, Nashville, TN, USA., Taylor J; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Xu ML; Department of Pathology and Laboratory Medicine, Yale School of Medicine, New Haven, CT, USA., Sweet K; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Sallman DA; Department of Malignant Hematology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Nimer SD; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA., Hourigan CS; Virginia Tech FBRI Cancer Research Center, Washington, DC, USA., Wei AH; Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Sauta E; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., D'Amico S; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Train, Milan, Italy., Asti G; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., Castellani G; Department of Medical and Surgical Sciences-DIMEC, University of Bologna, Bologna, Italy., Delleani M; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., Campagna A; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy., Borate UM; Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA., Sanz G; Instituto de Salud Carlos III, Valencia, Spain., Efficace F; Department of Haematology, La Fe University and Polytechnic Hospital, Valencia, Spain., Gore SD; Division of Cancer Prevention, National Cancer Institute, Rockville, MD, USA., Kim TK; Division of Hematology and Oncology, Vanderbilt Ingram Cancer Center and Vanderbilt University School of Medicine, Nashville, TN, USA., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rozman M; Hospital Clínic Barcelona, Barcelona, Spain., Orfao A; Haematology Department, University Hospital Salamanca, Salamanca, Spain., Wang SA; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Foucar MK; University of New Mexico, Albuquerque, NM, USA., Germing U; Department of Haematology, Oncology, and Clinical Immunology, Heinrich Heine University, Düsseldorf, Germany., Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany., Scheinberg P; Beneficência Portuguesa de São Paulo Hospital, São Paulo, Brazil., Miyazaki Y; Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan., Iastrebner M; Sanatorio Sagrado Corazón, Buenos Aires, Argentina., Kulasekararaj A; King's College Hospital NHS Foundation Trust, NIHR/Wellcome King's Clinical Research Facility, London, UK., Cluzeau T; Nice University Hospital, Nice, France., Kordasti S; Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College, London, UK., van de Loosdrecht AA; Department of Hematology, Amsterdam University Medical Center, VU University Medical Center-Cancer Center, Amsterdam, Netherlands., Ades L; Saint Louis Hospital, Paris Cité University, Paris, France., Zeidan AM; Hematology Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA., Della Porta MG; Center for Accelerating Leukemia/Lymphoma Research at Comprehensive Cancer Center, IRCCS Humanitas Research Hospital, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Milan, Italy. Electronic address: matteo.della_porta@hunimed.eu.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2024 Nov; Vol. 11 (11), pp. e862-e872. Date of Electronic Publication: 2024 Oct 09.
Autor:
Ghalehsari N; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York; NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York., Castillo Tokumori F; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York., Chen Z; Division of Biostatistics, Department of Population Science, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York., Liu M; NewYork-Presbyterian Brooklyn Methodist Hospital, Brooklyn, New York., Mayer SA; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York., Zeinah GA; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York., Shore TB; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York., Ritchie EK; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York., Silver RT; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York., Scandura JM; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York., Roboz GJ; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York., van Besien K; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York; UH Seidman Cancer Center, Cleveland, Ohio., Gomez-Arteaga A; Division of Hematology and Oncology, Department of Medicine, New York-Presbyterian Hospital/Weill Cornell Medicine, New York, New York. Electronic address: alg9117@med.cornell.edu.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Nov; Vol. 30 (11), pp. 1100.e1-1100.e11. Date of Electronic Publication: 2024 Sep 05.
Autor:
Aakash F; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Pathology, University of Texas Medical Branch, Galveston, Texas., Gisriel SD; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut; Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, Wisconsin., Zeidan AM; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, Yale Cancer Center, New Haven, Connecticut., Bennett JM; James P. Wilmot Cancer Center, Division of Hematopathology, University of Rochester Medical Center, Rochester, New York., Bejar R; Division of Hematology and Oncology, Moores Cancer Center, UC San Diego, La Jolla, California., Bewersdorf JP; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York., Borate UM; Division of Hematology, The Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Boultwood J; Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom., Brunner AM; Division of Hematology, Massachusetts General Hospital Brigham, Boston, Massachusetts., Buckstein R; Division of Medical Oncology/Hematology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Carraway HE; Leukemia Program, Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio., Churpek JE; Division of Haematology, Oncology, and Palliative Care, Department of Medicine, Carbone Cancer Center, University of Wisconsin-Madison, Madison, Wisconsin., Daver NG; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas., DeZern AE; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, Maryland., Efficace F; Health Outcomes Research Unit, Italian Group for Adult Hematologic Diseases (GIMEMA), Rome, Italy., Fenaux P; Service d'hématologie, Hôpital Saint-Louis (Assistance Publique Hôpitaux de Paris), Université de Paris-Cité, Paris, France., Figueroa ME; Biochemistry & Molecular Biology, Sylvester Comprehensive Cancer Center. University of Miami Miller School of Medicine, Miami, Florida., Garcia-Manero G; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas., Gore SD; Cancer Therapy Evaluation Program, National Cancer Institute, Rockville, Maryland., Greenberg PL; Division of Hematology, Department of Medicine, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Griffiths EA; Roswell Park Comprehensive Cancer Center, Buffalo, New York., Halene S; Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, Yale Cancer Center, New Haven, Connecticut., Hourigan CS; Fralin Biomedical Research Institute, Virginia Tech FBRI Cancer Research Center, Washington, District of Columbia., Kim TK; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Kim N; NCI, NIH, Bethesda, Maryland., Komrokji RS; Malignant Hematology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Kutchroo VK; Brigham and Women's Hospital, Boston, Massachusetts., List AF; Chief Scientific Officer, Stelexis Therapeutics, New York, New York., Little RF; Cancer Therapy Evaluation Program, National Cancer Institute, Rockville, Maryland., Majeti R; Division of Hematology, Department of Medicine, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California., Nazha A; Department of Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania., Nimer SD; Division of Hematology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida., Odenike O; Leukemia Program, Section of Hematology/Oncology, University of Chicago Medicine and University of Chicago Comprehensive Cancer Center, Chicago, Illinois., Padron E; Malignant Hematology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Patnaik MM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota., Platzbecker U; Department of Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany., Della Porta MG; IRCCS Humanitas Research Hospital, Department of Biomedical Sciences, Humanitas University, Milan, Italy., Roboz GJ; Weill Cornell Medical College and New York Presbyterian Hospital, New York, New York., Sallman DA; Malignant Hematology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Santini V; Myelodysplastic Syndromes Unit, Department of Experimental and Clinical Medicine, Hematology, Azienda Ospedaliero Universitaria Careggi, University of Florence, Florence, Italy., Sanz G; Health Research Institute La Fe, Valencia, Spain; Hospital Universitario y Politécnico La Fe, Valencia, Spain; CIBERONC, IS Carlos III, Madrid, Spain., Savona MR; Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee., Sekeres MA; Division of Hematology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida., Stahl M; Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts., Starczynowski DT; Division of Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital, Cincinnati, Ohio., Steensma DP; David Steensma LLC, Cambridge, Massachusetts., Taylor J; Division of Hematology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida., Abdel-Wahab O; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York., Wei AH; Department of Haematology, Royal Melbourne Hospital, Walter and Eliza Hall Institute of Medical Research, University of Melbourne, Victoria, Australia., Xie Z; Malignant Hematology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Xu ML; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut., Hasserjian RP; Department of Pathology, Massachusetts General Hospital Brigham, Boston, Massachusetts., Loghavi S; Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: Sloghavi@mdanderson.org.
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2024 Sep 23; Vol. 37 (12), pp. 100615. Date of Electronic Publication: 2024 Sep 23.
Autor:
DiNardo CD; Department of Leukemia, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX., Roboz GJ; Clinical and Translational Leukemia Programs, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY., Watts JM; Division of Hematology, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL., Madanat YF; Division of Hematology and Oncology, UT Southwestern Medical Center, Dallas, TX., Prince GT; Division of Hematologic Malignancy, Johns Hopkins Hospital, Baltimore, MD., Baratam P; Division of Hematology and Oncology, Medical University of South Carolina, Charleston, SC., de Botton S; Hematologie Clinique, Institut Gustave Roussy, Villejuif, Faculté Paris-Saclay, Institut Gustave Roussy, Villejuif, France., Stein A; Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA., Foran JM; Division of Hematology & Medical Oncology, Mayo Clinic, Jacksonville, FL., Arellano ML; Department of Hematology and Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA., Sallman DA; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL., Hossain M; Servier Pharmaceuticals, LLC, Boston, MA., Marchione DM; Servier Pharmaceuticals, LLC, Boston, MA., Bai X; Servier Pharmaceuticals, LLC, Boston, MA., Patel PA; Servier Pharmaceuticals, LLC, Boston, MA., Kapsalis SM; Servier Pharmaceuticals, LLC, Boston, MA., Garcia-Manero G; Department of Leukemia, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX., Fathi AT; Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.
Publikováno v:
Blood advances [Blood Adv] 2024 Aug 13; Vol. 8 (15), pp. 4209-4220.
Autor:
Cortes J; Department of Medicine, Georgia Cancer Center, Augusta University, Augusta, GA, USA., Jonas BA; Department of Internal Medicine, University of California Davis School of Medicine, Sacramento, CA, USA., Schiller G; Department of Internal Medicine, Hematology/Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Mims A; Division of Hematology, The Ohio State University, Columbus, OH, USA., Roboz GJ; Department of Hematology and Medical Oncology, Weill Cornell Medicine and The New York Presbyterian Hospital, New York, NY, USA., Wei AH; Department of Haematology, The Alfred Hospital, Melbourne, Australia., Montesinos P; Department of Hematology, Hospital Universitari i Politècnic La Fe, Valencia, Spain., Ferrell PB; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Yee KW; Cancer Clinical Research Unit, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Fenaux P; Service d'Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France., Schwarer A; Department of Hematology, Box Hill Hospital, Monash University and Eastern Health Clinical School, Melbourne, Australia., Watts JM; Division of Hematology, Department of Medicine, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL, USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2024 Aug; Vol. 65 (8), pp. 1145-1152. Date of Electronic Publication: 2024 Mar 27.
Autor:
Konopleva MY; University of Texas, MD Anderson Cancer Center, Houston, TX. Electronic address: mkonople@mdanderson.org., Dail M; Genentech, Inc., South San Francisco, CA., Daver NG; University of Texas, MD Anderson Cancer Center, Houston, TX., Garcia JS; Dana-Farber Cancer Institute, Boston, MA., Jonas BA; University of California Davis Comprehensive Cancer Center, Sacramento, CA., Yee KWL; Princess Margaret Cancer Centre, Toronto, ON, Canada., Kelly KR; University of Southern California, Los Angeles, CA., Vey N; Hematologie Clinique, Institut Paoli Calmettes, Marseille, France., Assouline S; Jewish General Hospital, Montreal, QC, Canada., Roboz GJ; Weill-Cornell Medical College, New York Presbyterian, New York, NY., Paolini S; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy., Pollyea DA; University of Colorado, Division of Hematology, Aurora, CO., Tafuri A; Department of Clinical and Molecular Medicine, University Hospital Sant'Andrea-Sapienza, Rome, Italy., Brandwein JM; Division of Hematology, University of Alberta, Edmonton, AB, Canada., Pigneux A; Bordeaux Haut-Leveque University Hospital, Pessac, France., Powell BL; Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC., Fenaux P; Hôpital Saint-Louis, Université Paris Diderot, Paris, France., Olin RL; University of California San Francisco, San Francisco, CA., Visani G; Hematology, Ospedale San Salvatore, Pesaro, Italy., Martinelli G; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Onishi M; Genentech, Inc., South San Francisco, CA., Wang J; Genentech, Inc., South San Francisco, CA., Huang W; Genentech, Inc., South San Francisco, CA., Dunshee DR; Genentech, Inc., South San Francisco, CA., Hamidi H; Genentech, Inc., South San Francisco, CA., Ott MG; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Hong WJ; Prelude Therapeutics, Wilmington, DE., Andreeff M; University of Texas, MD Anderson Cancer Center, Houston, TX.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Jun; Vol. 24 (6), pp. 364-374. Date of Electronic Publication: 2024 Jan 18.